1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine) | Trials (butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine) | Recent Studies (post-2010) (butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 31 | 1 | 17 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calixto, JB; Henriques, Md; Kassuya, CA; Menezes-de-Lima, O; Nascimento, AF | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine
| Article | Year |
|---|---|
Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bradykinin; Carrageenan; Dinoprostone; Dose-Response Relationship, Drug; Edema; Foot; Hindlimb; Histamine; Indomethacin; Injections, Intraperitoneal; Leukocytes; Lipoxins; Male; Mice; Neutrophil Infiltration; Oligopeptides; Platelet Activating Factor; Pleurisy; Receptors, Lipoxin | 2006 |